INTRODUCTION
Scar formation following surgery or trauma is common, and some scars gradually become reddish, hard, or hypertrophic. Scars are classified as hypertrophic, keloid, atrophic, or acne scars. Hypertrophic scars are firm and protrude due to increased collagen expression, but unlike keloid scars they do not extend beyond the margin of the original wound [
1].
Laser treatment for scars has improved over the past three decades and provides a less invasive, less painful treatment option [
1]. The most recent cutaneous laser technique is fractional photothermolysis, which thermally alters a “fraction” of the skin, leaving untouched areas of normal skin that rapidly repopulate the ablated columns of tissue. To date, there are few studies regarding the effectiveness of ablative fractional carbon dioxide (CO
2) laser for treating hypertrophic scars.
Platelets contain numerous granules and vast number of bioactive molecules that can facilitate homeostasis and wound healing. For these reasons, platelet-rich plasma (PRP) is increasingly being applied to clinical cases [
1]. PRP is concentrated by centrifuging whole blood and then extracting a small volume of residual plasma. Autologous PRP is immunologically inert and contains the proper ratio of growth factors and cytokines [
2]. Furthermore, additional equipment is not required to store PRP, and the processing cost is relatively low. Here we describe the outcomes of combining fractional CO
2 laser therapy in combination with PRP to reduce a hypertrophic scar.
DISCUSSION
Scar treatment has evolved over time. In the past, surgical excision was the most common treatment for hypertrophic scars, but more than half of these cases relapsed. Furthermore, this invasive procedure was unpleasant and painful.
Fractional ablative CO
2 laser improves rhytides, dyschromia, and textural irregularities and inhibits early stage scar progression. In addition, it was recently reported that ablative fractional CO
2 laser can resurface mature burn scars to correct abnormal texture, thickness, and stiffness [
6]. Compared to the previous ablative resurfacing technique, this procedure is less invasive and allows more rapid recovery.
Ablative CO
2 laser devices deliver more intense power to the scar tissue than non-ablative fractionated devices. It can ablate both the epidermis and dermis with significant heating of the adjacent dermal collagen. These thermal alterations change the collagen’s helical structure [
7]. Swelling, erythema, and other significant adverse effects can limit ablative laser use. While non-ablative lasers have described as safer, the outcomes can be unsatisfactory, and the total treatment takes longer [
5]. Compared to non-ablative fractional laser devices, ablative fractional CO
2 laser resurfacing can leave tiny holes made by tissue vaporization and tighten adjacent tissue by collapsing the small vaporized columns [
8]. These holes made with a fractional CO
2 ablative laser can also be used as a PRP delivery route. The fractional laser technique characteristically spares the tissue surrounding each column, facilitating rapid epidermal regeneration [
9]. Mechanistically, this is thought to be due to the rapid migration of viable keratinocyte present at the peripheral wound edges [
10,
11]. It induces collagen regeneration and remodeling in the dermal layer while epidermal stems cells in surrounding residual skin islands proliferate until the wound is healed. As a result, treatment with fractional CO
2 lasers minimizes patient inconvenience and post-treatment complications. It also improves scar contour and patient tolerability compared to previous ablative CO
2 and Er:YAG lasers. The LineXel fractional CO
2 laser (UTI Co., Ltd, Seoul, Korea) was used for all 11 laser treatments. In this case, we used an average pulse duration of 500 ms in the central area of wound and 200 to 250 ms in the marginal area (maximum duration: 1,400 ms), with a distance of 0.8 to 0.9 mm [
12].
PRP has been reported to aid the healing of different tissues, likely due to the number of bioactive molecules released and the stimulation of cell proliferation. Activated platelets secrete intracellular granules that contain platelet-derived growth factor (PDGF), transforming growth factor alpha (TGF-α) and beta (TGF-β), epidermal growth factor, basic fibroblastic growth factor, and vascular endothelial growth factor. These factors are known to regulate processes including cell migration, attachment, proliferation, and differentiation [
9]. They stimulate epidermal cell proliferation, promote angiogenesis, and induce collagen synthesis, all of which decrease erythema. Platelets have various molecules related to angiogenesis and vascular modeling. PRP seems to induce the appropriate level of angiogenesis without causing unnecessary vessel formation. PRP also reduces transient pigmentation caused when the fractional laser destroys the basal cell layer. TGF-β in PRP is known to stimulate the secretion of basement membrane proteins such as laminin, collagen IV, and tenascin. Those molecules can hasten repair of the basement membrane and might reduce post-inflammatory hyperpigmentation, resulting in less pigmentation. Also, thicker collagen bundles were observed in specimens from the PRP-treated side [
10]. This enhanced collagen tissue facilitates the remodeling effect of PRP. PDGF is a potent mitogen of mesenchymal stem cells. PDGF and TGF-β in PRP also promote the synthesis of collagen and other extracellular matrix proteins, which helps regenerate the epidermis and dermis damaged by ablative laser treatment. Finally, activated PRP becomes a gel-like material containing fibrin, which can be used as biologic glue [
10]. All these reactions are depicted in
Fig. 4. According to a previous study on PRP, it is effective and safe treatment for atrophic scars with short downtime and good tolerability [
11]. Based on the findings in that report, we hypothesized that the laser/PRP combination therapy could be applied to hypertrophic scars. Indeed, the patient reported less pain, swelling, edema, erythema, and pigmentation and a shorter epithelization period.
The shoulder is the joint most frequently affected by trauma or burn injury, and this can lead to significant functional limitations [
13]. As we did not expect spontaneous resolution in this patient, laser management was performed to prevent functional loss.
Our study has two limitations. First, the photographer did not take pictures with the same light brightness at the same location, so result interpretation is subjective. Second, there was no decrease in irritation, and the length and width of the scar did not change. To clarify the clinical outcome and the mechanism of synergistic effects, additional studies using PRP injection and fractional CO2 laser should be performed.
In summary, the volume, contour, and pigmentation of the scar improved after combined therapy with 1 PRP injections and 11 fractional CO2 laser treatments. This case provides evidence of the potential benefits of using PRP as an adjuvant to fractional laser in the treatment of hypertrophic scars. The superiority of the combination was clearly evident in several aspects, including the rapidity and degree of scar improvement, fewer side effects, and shorter downtime.